Danone has launched a drinkable yogurt product under its Oikos brand in the US which looks to target users of Ozempic and other GLP-1 weight loss drugs. The product, called Oikos Fusion, is designed ...
NEW YORK, May 16 (Reuters) - (This May 16 story has been refiled to say that Grant is the global deputy CEO of Danone, not the deputy CEO of Danone Americas, in paragraph 2) Danone (DANO.PA), opens ...
Danone said its Oikos Fusion drinks were “the first and only product” in the US yogurt category “specifically created and positioned to support the unique nutrition needs of GLP-1 users”. Credit: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results